BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1161 related articles for article (PubMed ID: 28280249)

  • 1. Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
    Kamphorst AO; Wieland A; Nasti T; Yang S; Zhang R; Barber DL; Konieczny BT; Daugherty CZ; Koenig L; Yu K; Sica GL; Sharpe AH; Freeman GJ; Blazar BR; Turka LA; Owonikoko TK; Pillai RN; Ramalingam SS; Araki K; Ahmed R
    Science; 2017 Mar; 355(6332):1423-1427. PubMed ID: 28280249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the role of negative T cell costimulatory pathways in CD4 and CD8 T cell-mediated alloimmune responses in vivo.
    Ito T; Ueno T; Clarkson MR; Yuan X; Jurewicz MM; Yagita H; Azuma M; Sharpe AH; Auchincloss H; Sayegh MH; Najafian N
    J Immunol; 2005 Jun; 174(11):6648-56. PubMed ID: 15905503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PD-1 blockade-unresponsive human tumor-infiltrating CD8
    Kim KH; Kim HK; Kim HD; Kim CG; Lee H; Han JW; Choi SJ; Jeong S; Jeon M; Kim H; Koh J; Ku BM; Park SH; Ahn MJ; Shin EC
    Cell Mol Immunol; 2021 Feb; 18(2):385-397. PubMed ID: 32332901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy.
    Im SJ; Hashimoto M; Gerner MY; Lee J; Kissick HT; Burger MC; Shan Q; Hale JS; Lee J; Nasti TH; Sharpe AH; Freeman GJ; Germain RN; Nakaya HI; Xue HH; Ahmed R
    Nature; 2016 Sep; 537(7620):417-421. PubMed ID: 27501248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential B7-CD28 costimulatory requirements for stable and inflationary mouse cytomegalovirus-specific memory CD8 T cell populations.
    Arens R; Loewendorf A; Redeker A; Sierro S; Boon L; Klenerman P; Benedict CA; Schoenberger SP
    J Immunol; 2011 Apr; 186(7):3874-81. PubMed ID: 21357256
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Control of memory CD8+ T cell differentiation by CD80/CD86-CD28 costimulation and restoration by IL-2 during the recall response.
    Fuse S; Zhang W; Usherwood EJ
    J Immunol; 2008 Jan; 180(2):1148-57. PubMed ID: 18178855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multiple layers of CD80/86-dependent costimulatory activity regulate primary, memory, and secondary lymphocytic choriomeningitis virus-specific T cell immunity.
    Eberlein J; Davenport B; Nguyen TT; Victorino F; Sparwasser T; Homann D
    J Virol; 2012 Feb; 86(4):1955-70. PubMed ID: 22156513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of CD28-B7 interactions in generation and maintenance of CD8 T cell memory.
    Suresh M; Whitmire JK; Harrington LE; Larsen CP; Pearson TC; Altman JD; Ahmed R
    J Immunol; 2001 Nov; 167(10):5565-73. PubMed ID: 11698427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival.
    Liu H; Qiu F; Wang Y; Zeng Q; Liu C; Chen Y; Liang CL; Zhang Q; Han L; Dai Z
    Front Immunol; 2019; 10():306. PubMed ID: 30863408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 4-1BB signaling synergizes with programmed death ligand 1 blockade to augment CD8 T cell responses during chronic viral infection.
    Vezys V; Penaloza-MacMaster P; Barber DL; Ha SJ; Konieczny B; Freeman GJ; Mittler RS; Ahmed R
    J Immunol; 2011 Aug; 187(4):1634-42. PubMed ID: 21742975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
    Kamphorst AO; Pillai RN; Yang S; Nasti TH; Akondy RS; Wieland A; Sica GL; Yu K; Koenig L; Patel NT; Behera M; Wu H; McCausland M; Chen Z; Zhang C; Khuri FR; Owonikoko TK; Ahmed R; Ramalingam SS
    Proc Natl Acad Sci U S A; 2017 May; 114(19):4993-4998. PubMed ID: 28446615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PD1-CD28 Fusion Protein Enables CD4+ T Cell Help for Adoptive T Cell Therapy in Models of Pancreatic Cancer and Non-hodgkin Lymphoma.
    Rataj F; Kraus FBT; Chaloupka M; Grassmann S; Heise C; Cadilha BL; Duewell P; Endres S; Kobold S
    Front Immunol; 2018; 9():1955. PubMed ID: 30214445
    [No Abstract]   [Full Text] [Related]  

  • 13. Dual Relief of T-lymphocyte Proliferation and Effector Function Underlies Response to PD-1 Blockade in Epithelial Malignancies.
    Balança CC; Scarlata CM; Michelas M; Devaud C; Sarradin V; Franchet C; Martinez Gomez C; Gomez-Roca C; Tosolini M; Heaugwane D; Lauzéral-Vizcaino F; Mir-Mesnier L; Féliu V; Valle C; Pont F; Ferron G; Gladieff L; Motton S; Tanguy Le Gac Y; Dupret-Bories A; Sarini J; Vairel B; Illac C; Siegfried-Vergnon A; Mery E; Fournié JJ; Vergez S; Delord JP; Rochaix P; Martinez A; Ayyoub M
    Cancer Immunol Res; 2020 Jul; 8(7):869-882. PubMed ID: 32295784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitors of B7-CD28 costimulation in urologic malignancies.
    Thompson RH; Kwon ED; Allison JP
    Immunotherapy; 2009 Jan; 1(1):129-39. PubMed ID: 20445772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue-specific differences in PD-1 and PD-L1 expression during chronic viral infection: implications for CD8 T-cell exhaustion.
    Blackburn SD; Crawford A; Shin H; Polley A; Freeman GJ; Wherry EJ
    J Virol; 2010 Feb; 84(4):2078-89. PubMed ID: 19955307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition.
    Hui E; Cheung J; Zhu J; Su X; Taylor MJ; Wallweber HA; Sasmal DK; Huang J; Kim JM; Mellman I; Vale RD
    Science; 2017 Mar; 355(6332):1428-1433. PubMed ID: 28280247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of Memory Phenotype T Lymphocyte Homeostasis: Role of Costimulation.
    Panda AK; Kim YH; Shevach EM
    J Immunol; 2022 Feb; 208(4):851-860. PubMed ID: 35039334
    [TBL] [Abstract][Full Text] [Related]  

  • 18. B7-CD28 interaction promotes proliferation and survival but suppresses differentiation of CD4-CD8- T cells in the thymus.
    Zheng X; Gao JX; Chang X; Wang Y; Liu Y; Wen J; Zhang H; Zhang J; Liu Y; Zheng P
    J Immunol; 2004 Aug; 173(4):2253-61. PubMed ID: 15294937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD8
    Huang B; Liu R; Wang P; Yuan Z; Yang J; Xiong H; Zhang N; Huang Q; Fu X; Sun W; Li L
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32606053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Striking dichotomy of PD-L1 and PD-L2 pathways in regulating alloreactive CD4(+) and CD8(+) T cells in vivo.
    Habicht A; Kewalaramani R; Vu MD; Demirci G; Blazar BR; Sayegh MH; Li XC
    Am J Transplant; 2007 Dec; 7(12):2683-92. PubMed ID: 17924994
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.